During the past decade, University of Padova Medical School conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Padova Medical School" #1 sponsor was "University of Padova" with 2 trials, followed by "Baxalta now part of Shire" with 1 trials sponsored, "NeoChord" with 1 trials sponsored, "Octapharma" with 1 trials sponsored and "Virginia Commonwealth University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Padova Medical School" #1 collaborator was "Biomedical Foundation for Cardiovascular Research of Padova" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Solvay Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Padova Medical School" are "Cardiovascular Diseases" (1 trials), "Cellular Apoptosis" (1 trials), "Cerebrovascular Trauma" (1 trials), "Congenital Antithrombin Deficiency" (1 trials) and "Endothelin System" (1 trials). Many other conditions were trialed in "University of Padova Medical School" in a lesser frequency.

Most popular intervention types in "University of Padova Medical School" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atenativ" (1 trials), "Atorvastatin - Cholestyramine - Sitosterol" (1 trials), "Marketed plasma-derived VWF/FVIII concentrate" (1 trials), "Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)" (1 trials) and "Sitagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Padova Medical School" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Padova Medical School". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Padova Medical School, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Padova Medical School, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".